| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |